RYTELO® (imetelstat) is indicated for treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia.
Categories
October Surprise 2016 - octobersurprise2016.orgOctober Surprise 2016 - octobersurprise2016.org - - The News And Times